Condition
Postmenopausal Bone Loss
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00399321CompletedPrimary
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
NCT01653275Not ApplicableCompleted
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
NCT00578981Not ApplicableCompleted
Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
NCT00165204Phase 2Completed
Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy
NCT00085956Phase 3CompletedPrimary
Effects of Arzoxifene on Bone Mass and the Uterus
Showing all 5 trials